(150 mg, 1.09 mmol) by method A gave 3,10-di(4-methoxyphenyl)-1,8-dithioxo-5,6,12,13-tetrahydro-1H,8H-
dipyrido[1,2-a:1',2'-e] [1,3,5,7]tetrazocine-2,4,9,11-tetracarbonitrile (3d) not containing the pyridotriazine 2j as
impurity. The analytically pure product was obtained by recrystallization from DMSO. Yield 70 mg (30%), beige
powder, mp >300°C. Found, %: C 61.48; H 3.45; N 18.90. C30H20N8O2S2. Calculated, %: C 61.21; H 3.42; N 19.03.
Reaction of 6-Amino-(4-methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3,5-dicarbonitrile (1d)
with 2-Phenylethylamine and Formalin. The reaction of pyridine 1d (306 mg, 1.08 mmol) and Ph(CH2)2NH2
(0.27 ml, 2.15 mmol) by method A gave 8-(4-methoxyphenyl)-3-(2-phenylethyl)-6-thioxo-1,3,4,6-tetrahydro-
2H-pyrido[1,2-a][1,3,5]triazine-7,9-dicarbonitrile (2k). Yield 390 mg (~84%), finely crystalline yellow powder,
mp >220°C (decomp.), Rf 0.53. The product was obtained in analytically pure form and, according to 1H NMR
spectroscopy, did not contain the tetrazocine 3d as impurity. Mass spectrum, m/z: 134.3 [H2C=N(CH2)2Ph+H]+,
307.3 [M-Ph(CH2)2NH2+H]+, 428.3 [М+H]+, 855.3 [2М+H]+. Found, %: C 67.20; H 5.02; N 16.52. C24H21N5OS.
Calculated, %: C 67.43; H 4.95; N 16.38.
Reaction of 6-Amino-4-(4-methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3,5-dicarbonitrile (1d)
with tert-Butylamine and Formalin. The reaction of pyridine 1d (320 mg, 1.13 mmol) and t-BuNH2 (0.5 ml,
4.76 mmol) by method A gave 3-(tert-butyl)-8-(4-methoxyphenyl)-6-thioxo-1,3,4,6-tetrahydro-2H-pyrido[1,2-a]-
[1,3,5]triazine-7,9-dicarbonitrile (2l). Yield 337 mg (78%), finely crystalline light-yellow powder, mp >250°C,
1
Rf 0.61 (acetone–hexane, 1:1). The product was obtained in analytically pure form and according to H NMR
spectroscopy did not contain tetrazocine 3d as impurity. Mass spectrum, m/z: 380.1 [М+H]+, 759.5 [2М+H]+.
Found, %: C 63.07; H 5.62; N 18.54. C20H21N5OS. Calculated, %: C 63.30; H 5.58; N 18.45.
Reaction of 6-Amino-4-(4-methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3,5-dicarbonitrile (1d)
with 2 equiv. of para-Toluidine and Formalin. The reaction of pyridine 1d (318 mg, 1.13 mmol) and para-
toluidine (241 mg, 2.25 mmol) by method A gave a mixture, that, according to 1H NMR spectroscopy, consisted
of ~75 mol% of 3-(4-methylphenyl)-8-(4-methoxyphenyl)-6-thioxo-1,3,4,6-tetrahydro-2H-pyrido[1,2-a]-
[1,3,5]triazine-7,9-dicarbonitrile (2m) (Rf 0.58) and ~25 mol% of 3,10-di(4-methoxyphenyl)-1,8-dithioxo-
5,6,12,13-tetrahydro-1H,8H-dipyrido[1,2-a:1',2'-e][1,3,5,7]tetrazocine-2,4,9,11-tetracarbonitrile (3d) (Rf 0.17).
Total yield 212 mg (corresponds to a ~31% yield of pyridotriazine 2m and ~21% of tetrazocine 3d of the
theoretically calculated on pyridine 1d), yellow powder.
Reaction of 6-Amino-4-(4-methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3,5-dicarbonitrile (1d) with
1 equiv. of para-Toluidine and Formalin. Et3N (0.35 ml, 2.52 mmol) was added to a suspension of pyridine 1d
(330 mg, 1.17 mmol) and para-toluidine (125 mg, 1.17 mmol) in EtOH (12 ml), and the mixture was heated with
vigorous stirring until completely dissolved. An excess of 37% formalin free from paraform impurity (1.5 ml,
20 mmol) was added to the obtained solution. The obtained mixture was refluxed with vigorous stirring for 3-5 min,
while the product began to crystallize. The mixture was stirred for 2 h at ~50°C, cooled, and left overnight. The
finely crystalline yellow precipitate that formed was filtered off and washed with water, alcohol, and petroleum ether. A
1
mixture that, according to H NMR spectroscopy, contained ~53 mol% of 8-(4-methoxyphenyl)-3-(4-methylphenyl)-
6-thioxo-1,3,4,6-tetrahydro-2H-pyrido[1,2-a][1,3,5]triazine-7,9-dicarbonitrile (2m) (Rf 0.55) and ~47 mol% of 3,10-di-
(4-methoxyphenyl)-1,8-dithioxo-5,6,12,13-tetrahydro-1H,8H-dipyrido-[1,2-a:1',2'-e][1,3,5,7]tetrazocine-2,4,9,11-
tetracarbonitrile (3d) (Rf 0.14) was obtained. Total yield 176 mg (corresponds to a ~16% yield of pyridotriazine 2m
and ~28% of tetrazocine 3d of the theoretically calculated on the pyridine 1d), yellow powder. 1H NMR spectrum, δ,
ppm (J, Hz): 2.23 (1.59Н, s, ArCH3); 3.83 (1.59H, s, ОCH3); 3.84* (2.82Н, s, 2ОCH3); 4.74* (0.94Н, dd, 2J = 13.1,
3
3J = 2.4, NHCH2N); 5.07 (1.06Н, br. s, 2-СН2); 6.05 (1.06Н, br. s, 4-СН2); 6.98 (1.06H, d, J = 8.3, H Ar);
7.00-7.04* (0.94H, м, NHCH2N); 7.07 (1.06H, d, 3J = 8.6, H Ar); 7.11* (1.88H, d, 3J = 8.5, H Ar); 7.16 (1.06H, d,
3J = 8.3, H Ar); 7.46 (1.06H, d, 3J = 8.6, H Ar); 7.51* (1.88H, d, 3J = 8.5, H Ar); 8.79* (0.94Н, dd, 3J = 2.4, 3J = 8.7,
2NH); 9.54 (0.53Н, br. s, NH). Mass spectrum, m/z: 120.1 (2m, [ArN=CH2+H]+), 295.5 (3d, [1/2M+H]+), 414.0 (2m
[М+H]+), 428.0 (2m [М+15]+), 589.0 (3d [M+H]+), 827.0 (2m [2М+H]+). According to HPLC-MS, the sample
contained compounds 3m and 3d in a ratio of ~7:8 (47 and 53%).
_______
*Signals of tetrazocine 3d.
1019